It is important to point out that patients with cancer often present with increased levels of both inflammatory parameters (especially CRP), reflecting cancer-related inflammation, and hemostatic biomarkers (eg, fibrinogen, D-dimer, FVIII activity), indicating cancer-induced hypercoagulability [[27], [28], [29]]. This evidence concerns the gene CRP and cancer.